Strategic Insights

Ain Shams University

Targeted Liposomal Nano-Therapy Combats Ehrlich Ascites Carcinoma with Reduced Toxicity and Enhanced Anticancer Efficacy

Researchers at Ain Shams University have made groundbreaking findings in the treatment of Ehrlich ascites carcinoma (EAC), a rapidly growing tumor model, by developing targeted liposomal nano-therapy combining anthocyanin and cisplatin. This innovative approach not only reduces systemic toxicity but also enhances anticancer efficacy against EAC, demonstrating a promising future